Cancer test strip BRAF 600/601 StripAssay®
proteinfor BRAF mutationscell

cancer test strip
cancer test strip
cancer test strip
Add to favorites
Compare this product


for cancers
Tested parameter
protein, for BRAF mutations
Sample type
clinical, cell
Analysis mode
DNA analysis


BRAF gene mutation assessment is indicated in colorectal cancer, advanced non-small cell lung cancer, melanoma and thyroid cancer. BRAF StripAssays® identify the most relevant mutations in the BRAF gene. BRAF encodes a serine/threonine protein kinase, which plays an important role in signaling pathways involved in cell proliferation and differentiation. Determination of BRAF V600 mutational status is recommended in metastatic colorectal cancer (mCRC) at the same time as RAS mutational status for prognostic assessment (and/or potential selection for clinical trials). Testing of patients with metastatic melanoma or advanced non-small cell lung cancer for BRAF V600 mutations prior to treatment is recommended, as BRAF V600 mutation positive patients may benefit from BRAF inhibitor therapy (e.g. dabrafenib, trametinib, vemurafenib).
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.